ADMA Biologics
ADMA
ADMA
55 hedge funds and large institutions have $115M invested in ADMA Biologics in 2018 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 18 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
8.93% more ownership
Funds ownership: 46.16% → 55.09% (+8.9%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
55
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$12.2M | |
| 2 | +$11.4M | |
| 3 | +$4.2M | |
| 4 |
CCM
Consonance Capital Management
New York
|
+$4.15M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.75M |
Top Sellers
| 1 | -$1.44M | |
| 2 | -$1.01M | |
| 3 | -$435K | |
| 4 |
Goldman Sachs
New York
|
-$429K |
| 5 |
Millennium Management
New York
|
-$199K |